A Systematic Review of Health Technology Assessments of Chimeric Antigen Receptor T-Cell Therapies in Young Compared With Older Patients
Amy Gye, Stephen Goodall, Richard De Abreu Lourenço
Topics & Concepts
MedicineChimeric antigen receptorDiscountingQuality-adjusted life yearCost effectivenessOncologyInternal medicineImmunotherapyCancerFinanceRisk analysis (engineering)EconomicsCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchHealth Systems, Economic Evaluations, Quality of Life